Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume → Wall Street legend who predicted 2021 tech crash issues new warning (From Chaikin Analytics) (Ad) Free ENSC Stock Alerts $0.62 +0.06 (+10.73%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Ensysce Biosciences Short Interest DataCurrent Short Volume9,600 sharesPrevious Short Volume4,100 sharesChange Vs. Previous Month+134.15%Dollar Volume Sold Short$5,679.36Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares7,330,000 sharesFloat Size6,630,000 sharesShort Percent of Float0.14%Today's Trading Volume547,496 sharesAverage Trading Volume1,037,329 sharesToday's Volume Vs. Average53% Short Selling Ensysce Biosciences ? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ad Weiss RatingsHow to Play the AI and Crypto Markets in One SwingI’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,600 shares $5,679.36 +134.2%0.1%0 $0.59 4/15/20244,100 shares $2,785.95 -76.6%0.1%0 $0.68 3/31/202417,500 shares $13,828.50 -69.0%0.6%0 $0.79 3/15/202456,500 shares $44,838.40 -34.4%1.9%0 $0.79 2/29/202486,100 shares $80,279.64 +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54,379.00 -91.0%2.1%0 $0.89 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 1/15/2024246,300 shares $337,431.00 +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239,242.00 +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185,370.00 +25.3%5.9%0.8 $1.11 11/30/2023133,300 shares $151,962.00 +96.6%4.8%0.9 $1.14 11/15/202367,800 shares $59,806.38 +11.3%2.4%0.9 $0.88 10/31/202360,900 shares $56,094.99 +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33,552.00 +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29,256.00 -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46,375.00 -4.0%1.1%0.1 $1.75 8/31/202327,600 shares $51,060.00 -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54,990.00 -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89,646.00 +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48,216.00 +24.9%1.4%0 $1.96 6/30/202319,700 shares $36,051.00 -2.5%2.4%0 $1.83 6/15/202320,200 shares $47,470.00 +6.3%2.5%0 $2.35 5/31/202319,000 shares $45,030.00 -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349,888.00 +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296,250.00 +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194,366.57 +5.9%3.9%0.2 $3.99 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351,904.20 +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96,479.70 -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167,872.00 -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367,500.00 +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55,321.90 -9.9%1.6%0 $0.77 12/30/202279,700 shares $59,775.00 -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131,340.06 -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915,530.00 +128.9%17.3%0.3 $2.90 11/15/2022137,900 shares $297,864.00 -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484,500.00 -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144,630.90 -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249,400.00 -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551,840.00 +134.6%7.4%1 $0.34He cracked the code to crypto… (Ad)Juan Villaverde has cracked the code to crypto.Click now for the best way into the newest AI projects ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 9,600 shares of ENSC short. 0.14% of Ensysce Biosciences' shares are currently sold short. Learn More on Ensysce Biosciences' current short interest. What is a good short interest percentage for Ensysce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.14% of Ensysce Biosciences' floating shares are currently sold short. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 9,600 shares, an increase of 134.1% from the previous total of 4,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ensysce Biosciences' float size? Ensysce Biosciences currently has issued a total of 7,330,000 shares. Some of Ensysce Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ensysce Biosciences currently has a public float of 6,630,000 shares. How does Ensysce Biosciences' short interest compare to its competitors? 0.14% of Ensysce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ensysce Biosciences: Longeveron Inc. (3.56%), Artelo Biosciences, Inc. (0.15%), Soligenix, Inc. (6.22%), Exicure, Inc. (1.75%), Tharimmune, Inc. (1.03%), Evoke Pharma, Inc. (0.56%), GT Biopharma, Inc. (0.48%), Revelation Biosciences, Inc. (1.09%), Alzamend Neuro, Inc. (0.47%), Phio Pharmaceuticals Corp. (4.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Longeveron Short Interest Artelo Biosciences Short Interest Soligenix Short Interest Exicure Short Interest Tharimmune Short Interest Evoke Pharma Short Interest GT Biopharma Short Interest Revelation Biosciences Short Interest Alzamend Neuro Short Interest Phio Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders